Powered by
ANN ARBOR–CareEvolution has announced a membership with the Decentralized Trials & Research Alliance (DTRA) to collaborate in the efforts to improve global adoption and education surrounding decentralized research, participant-centric trial …
ANN ARBOR–HistoSonics Inc., the developer and manufacturer of a completely non-invasive platform and proprietary sonic beam therapy, announced the publication of results from their prospective Phase I clinical trial, conducted …
ANN ARBOR—Strata Oncology Inc., developers of novel cancer treatment, announced that Lehigh Valley Topper Cancer Institute and the University of Michigan Health Rogel Cancer Center have joined as clinical trial sites …
ROYAL OAK—Immunis.AI Inc., a biotech company developing noninvasive blood-based tests for disease, announced the publication of pivotal results from its clinical trial, Evaluation of an RNAseq-based Immunogenomic Liquid Biopsy Approach …
CANTON TWP.—Officials at MMS Holdings, the Canton Township-based contract pharmaceutical research firm, announced that the company’s MMS Academy has launched new courses in inspection readiness and clinical programming for clinical …
ANN ARBOR—Esperion Therapeutics Inc. (Nasdaq: ESPR), the Ann Arbor-based developer of cholesterol-lowering drugs, announced that the results of a Phase 2 study evaluating the combination of its Nexletol (bempedoic acid) …
PRINCETON, N.J.—Certara (Nasdaq: CERT), the New Jersey-based biosimulation company, has licensed the Anonymize software to anonymize clinical data from Canton Township-based TrialAssure. TrialAssure’s Anonymize allows clinical trial sponsors to anonymize …
CANTON TWP.–MMS Holdings, a contract research organization for the pharmaceutical industry, has joined the Decentralized Trials and Research Alliance, an organization launched in December to unite healthcare companies, regulators, patient …
LOS ANGELES—Officials at the St. Baldrick’s Foundation has named two Michigan hospitals among 17 grant winners of $819,000 in grants to advance research into children’s cancers. The Los Angeles-based foundation …
DETROIT—Officials at the Karmanos Cancer Institute in Detroit have announced the launch of a new clinical trials study information portal (SIP) at www.karmanos.org/opentrials. The SIP website, which is integrated with …